Swiss stocks - Factors to watch on Feb 18

ZURICH Mon Feb 18, 2013 12:57am EST

Related News

ZURICH Feb 18 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Monday:

NOVARTIS

* Chairman Daniel Vasella said he will receive up to 72 million Swiss francs ($77.94 million) over the next six years after leaving the company this month, news that might play into the hands of supporters of a referendum to limit "fat cat" pay.

The news has unleashed a wave of indignation among activist shareholders and politicians.

* U.S. regulators approved Novartis AG's Zortress as the first new drug in more than a decade for preventing organ rejection in adult patients receiving a liver transplant, the company said on Friday.For related news click on

COMPANY STATEMENTS

* Nobel Biocare shareholder Oskar Ronner published a statement saying he no longer wished to join the board of directors after the board rejected the election of two other candidates he had proposed.

ECONOMY

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.